Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines.

Sadeh H, Razi T, Arbel R, Netzer D, Meiri G

Open source

DOI
10.1177/10445463251404404
Published
2026 Jan
Container
Journal of child and adolescent psychopharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10445463251404404,
  title = {Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines.},
  author = {Sadeh H and Razi T and Arbel R and Netzer D and Meiri G},
  year = {2026},
  journal = {Journal of child and adolescent psychopharmacology},
  doi = {10.1177/10445463251404404},
  url = {https://doi.org/10.1177/10445463251404404}
}

RIS

TY  - JOUR
TI  - Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines.
AU  - Sadeh H
AU  - Razi T
AU  - Arbel R
AU  - Netzer D
AU  - Meiri G
PY  - 2026
JO  - Journal of child and adolescent psychopharmacology
DO  - 10.1177/10445463251404404
UR  - https://doi.org/10.1177/10445463251404404
ER  - 

APA

H, S., T, R., R, A., D, N., & G, M. (2026). Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines.. Journal of child and adolescent psychopharmacology. https://doi.org/10.1177/10445463251404404

Source records